Detalhe da pesquisa
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546625
2.
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial.
Antimicrob Agents Chemother
; : e0053624, 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842323
3.
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
Trop Med Int Health
; 26(4): 421-427, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406316
4.
Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.
Eur Respir J
; 55(3)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31862767
5.
Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
BMC Infect Dis
; 20(1): 675, 2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938422
6.
Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38419566
7.
Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia.
BMC Infect Dis
; 19(1): 908, 2019 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664926
8.
Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
BMC Med
; 14(1): 187, 2016 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855693
9.
Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
BMC Infect Dis
; 16: 362, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465783
10.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980911
11.
Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016-2018.
Int J Environ Res Public Health
; 18(9)2021 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33946457
12.
Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?
Int J Environ Res Public Health
; 18(6)2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33809168
13.
Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019.
Int J Environ Res Public Health
; 18(14)2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34300026
14.
Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan.
Int J Environ Res Public Health
; 18(12)2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34204519
15.
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017-2018.
Int J Environ Res Public Health
; 18(6)2021 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799350
16.
Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan.
Int J Environ Res Public Health
; 18(11)2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072161
17.
Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013-2018.
Int J Environ Res Public Health
; 18(9)2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33925705
18.
Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?
Int J Environ Res Public Health
; 18(8)2021 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33921547
19.
Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis.
Int J Environ Res Public Health
; 18(8)2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924701
20.
Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012-2019: Are We on the Right Track?
Int J Environ Res Public Health
; 18(9)2021 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924862